A REVIEW OF LINK ALTERNATIF MBL77

Not all patients with CLL demand therapy. Despite all current advances, the iwCLL however endorses watchful observation for people with asymptomatic illness.86 This suggestion is based on at the very least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Mortality ri